TeraRecon is First to Pass Stringent New US Department of Defense Security Requirements

Las Vegas, NV (HIMSS18), March 07, 2018 (GLOBE NEWSWIRE) -- Las Vegas, NV – March 7th, 2018:  TeraRecon today announced that its iNtuition™ Advanced Visualization solution has been granted an Authority to Operate (ATO) on networks in the U.S. Department of Defense (DoD).  TeraRecon is demonstrating the ATO-approved iNtuition, as well as complementary technologies, this week at the Healthcare Information Management Systems Society (HIMSS18) annual meeting in Las Vegas, Nevada, where two of the keynote speakers are top Department of Defense and Veterans Affairs officials.

EnvoyAI, Ambra Health, and TeraRecon Deliver First End-to-End AI Strategy

Leading AI, image sharing, and advanced viewing platforms simplify AI access and workflow

Las Vegas, NV – March 6th, 2018 – TeraRecon, EnvoyAI and Ambra Health, today announced a new collaboration to provide an AI-enhanced image exchange workflow. The partnership will enable healthcare providers to immediately implement an AI strategy through an Ambra image exchange workflow with access to the entire portfolio of AI algorithm solutions available on the EnvoyAI Exchange, leveraging their current PACS system or the full range of TeraRecon viewers. These AI workflows will be on display at the Healthcare Information & Management Systems Society (HIMSS18) annual meeting in Las Vegas, Nevada March 6th- 8th, 2018.

TeraRecon launches EnvoyAI distributorship to resell the 35+ algorithms on the EnvoyAI Exchange

Chicago, IL – November 27, 2017: Advanced Visualization solution provider, TeraRecon (www.terarecon.com) today announced a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes the most content-rich artificial intelligence marketplace, called the EnvoyAI Exchange, as well as a refined suite of market-ready AI-enablement technologies aimed at fostering broader access and clinical use of medical imaging algorithms within busy radiology practices. As a distributor, TeraRecon will offer instant access to the platform containing more than 35 algorithms and focus its initial sales efforts on two FDA-cleared algorithms from Imbio and icometrix, as well as one cleared algorithm of its own.

University of Utah Health Extends 3D Printing to Physicians with TeraRecon

Foster City, CA – November 25th, 2017: University of Utah Hospitals & Clinics (healthcare.utah.edu), together with TeraRecon (www.terarecon.com)the market leading advanced visualization solution provider, today announced the launch of TeraRecon’s 3D Print Pack Portal within the University of Utah Health’s clinical environment, extending 3D printing access to physicians throughout the health system

TeraRecon Announces Major iNtuition Release

Foster City, CA – October 24th, 2017: TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, announced the release of version 4.4.13 of their iNtuition™ software, bringing over 175 new feature and workflow enhancements to its best-in-class advanced visualization platform. 

TeraRecon acquires McCoy Medical Technologies and spins out a new AI platform company

 

TeraRecon acquires McCoy Medical Technologies and spins out a new AI platform company aimed at simplifying access and use of 3rd party computer vision and artificial intelligence applications

Pittsburgh, PA – June 1st, 2017: TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, today announced the acquisition of machine learning company, McCoy Medical Technologies, (www.mccoymed.com), at the Society for Imaging Informatics in Medicine’s Annual Meeting (SIIM17) in Pittsburgh, PA.

TeraRecon Japan Announces Partnership with CV Imaging Science and CVIC

Tokyo, Japan – April 13, 2017:CV Imaging Science Co., Ltd. (Headquarters: Taito-ku, Tokyo, President and CEO: Yoshihiro Furusawa, hereinafter referred to as CVIS), CVIC Medical Corporation (Headquarters: Shinjuku-ku, Tokyo, President: Masahiro Terashima, hereinafter CVIC), and TeraRecon Incorporated (Headquarters: California State, President and CEO Jeffrey Sorenson, Japan Branch: Minato-ku, Tokyo, GM Suzuki Atsushi, hereinafter TeraRecon) made an announcement today that they have contracted “Luminary-Beta Site Agreement” for future development of advanced applications for medical image analysis.

TeraRecon Adds Complete Product Lineup to the U.K. NHS Supply Chain

Foster City, CA – February 28, 2017: TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, has selected to participate in the new UK NHS Supply Chain Framework. The NHS Supply Chain provides high-quality, cost-effective, and patient-focused healthcare products and supply chain services to the UK’s National Health Service (NHS), including hundreds of NHS trusts and healthcare organizations.

TeraRecon Demonstrates Deep Learning Workflow at HIMSS17

Orlando, FL – February 21, 2017: TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, is demonstrating their Within Image Analysis (WIA) Cloud* machine learning solution this week at Healthcare Information & Management Systems Society (HIMSS17) Conference and Exhibition in Orlando, Florida.  WIA Cloud aims to accelerate and automate image interpretation & advanced post-processing tasks using artificial intelligence to eliminate repetitive operator tasks.

TeraRecon Premiers HoloPack Portal at HIMSS17

Orlando, FL – February 20, 2017: TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, debuted their new high-performance, cloud-based augmented reality solution, the HoloPack™ Portal*, today at the Health Information & Management Systems Society (HIMSS17) Annual Conference & Exhibition, in Orlando, Florida.  The HoloPack Portal extends the TeraRecon viewing platform to provide a full-spectrum user experience that is applicable to both clinical experts and their patients.